Pentasa
Brand Name: Pentasa
Generic Name: Mesalazine
Active
Registration Number
DR-XY43892
Dosage Form
Prolonged-Release Tablet
Issuance Date
June 16, 2024
Expiry Date
November 14, 2029
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength1 g
PackagingAlu/Alu Blister Pack x 10's (Box of 60's)
Classification
C
Classification
Prescription Drug (RX)
P
Pharmacologic
Bowel Anti-inflammatory
A
Application
Renewal
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
MesalazineActive
Monograph: Mesalazine